Mira Pharmaceuticals holds annual shareholder meeting with 63.06% of shares represented

• Mira Pharmaceuticals held its 2026 annual shareholder meeting on Sept. 11, 2026.
• Shareholders backed the board’s slate of director nominees, setting their terms through the next annual meeting.
• Ratification of Salberg & Company, P.A. as independent auditor for the year ending Dec. 31, 2026 was approved.
• An adjournment authority to seek additional proxies if needed to secure support for the director slate or auditor ratification was authorized.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Mira Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-042927), on September 16, 2026, and is solely responsible for the information contained therein.